ENSA expression correlates with attenuated tumor propagation in liver cancer

Biochemical and Biophysical Research Communications

Volumn 442, Issue 1-2, 2013, Pages 56-61

  Chen, Yao Li ^a,b   Kuo, Ming Han ^c   Lin, Ping Yi ^a   Chuang, Wan Ling ^a   Hsu, Chia Chen ^c   Chu, Pei Yi ^d   Lee, Chia Huei ^e   Huang, Tim H M ^f   Leu, Yu Wei ^c   Hsiao, Shu Huei ^c  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^d St Martin De Porres Hospital   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^f UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Chromatin immunoprecipitation; DNA methylation; Epigenetic; Liver cancer

Indexed keywords

ENDOSULFINE ALPHA; MICROTUBULE ASSOCIATED SERINE THREONINE PROTEIN KINASE LIKE PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL DIFFERENTIATION; CELL TRANSFORMATION; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GENE CONTROL; GENE INTERACTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; LIVER CANCER; LIVER CARCINOGENESIS; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METHYLATION;

MUS;

5-AZA; 5-AZA-2′-DEOXYCYTIDINE; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; ENDOSULFINE ALPHA; ENSA; EPIGENETIC; H3K27ME3; HISTONE 3 LYSINE 27 TRIMETHYLATION; LIVER CANCER; MESENCHYMAL STEM CELL; MSC;

ANIMALS; BREAST NEOPLASMS; CELL PROLIFERATION; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; LIVER NEOPLASMS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM INVASIVENESS; PEPTIDES; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES;

EID: 84889685785     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.10.165     Document Type: Article

References (36)

1. L. Heron, A. Virsolvy, F. Apiou, A. Le Cam, and D. Bataille Isolation, characterization, and chromosomal localization of the human ENSA gene that encodes alpha-endosulfine, a regulator of beta-cell K(ATP) channels Diabetes 48 1999 1873 1876
2. F. Thameem, V.S. Farook, X. Yang, Y.H. Lee, P.A. Permana, C. Bogardus, and M. Prochazka The transcribed endosulfine alpha gene is located within a type 2 diabetes-linked region on 1q: sequence and expression analysis in pima Indians Mol. Genet. Metab. 81 2004 16 21
3. H. Wang, R.L. Craig, J. Schay, W. Chu, S.K. Das, Z. Zhang, and S.C. Elbein Alpha-endosulfine, a positional and functional candidate gene for type 2 diabetes: molecular screening, association studies, and role in reduced insulin secretion Mol. Genet. Metab. 81 2004 9 15
4. E. Voets, and R.M. Wolthuis MASTL is the human orthologue of greatwall kinase that facilitates mitotic entry, anaphase and cytokinesis Cell Cycle 9 2010 3591 3601
5. T. Lorca, and A. Castro The greatwall kinase: a new pathway in the control of the cell cycle Oncogene 32 2013 537 543
6. S. Mochida, S.L. Maslen, M. Skehel, and T. Hunt Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis Science 330 2010 1670 1673
7. A. Bird DNA methylation patterns and epigenetic memory Genes Dev. 16 2002 6 21
8. R. Jaenisch, and A. Bird Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals Nat. Genet. 33 Suppl. 2003 245 254
9. S.B. Baylin, and J.E. Ohm Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer 6 2006 107 116
10. A. Eden, F. Gaudet, A. Waghmare, and R. Jaenisch Chromosomal instability and tumors promoted by DNA hypomethylation Science 300 2003 455
11. F. Gaudet, J.G. Hodgson, A. Eden, L. Jackson-Grusby, J. Dausman, J.W. Gray, H. Leonhardt, and R. Jaenisch Induction of tumors in mice by genomic hypomethylation Science 300 2003 489 492
12. I.W. Teng, P.C. Hou, K.D. Lee, P.Y. Chu, K.T. Yeh, V.X. Jin, M.J. Tseng, S.J. Tsai, Y.S. Chang, C.S. Wu, H.S. Sun, K.D. Tsai, L.B. Jeng, K.P. Nephew, T.H. Huang, S.H. Hsiao, and Y.W. Leu Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells Cancer Res. 71 2011 4653 4663
13. Y.L. Chen, C.J. Ko, P.Y. Lin, W.L. Chuang, C.C. Hsu, P.Y. Chu, M.Y. Pai, C.C. Chang, M.H. Kuo, Y.R. Chu, C.H. Tung, T.H. Huang, Y.W. Leu, and S.H. Hsiao Clustered DNA methylation changes in polycomb target genes in early-stage liver cancer Biochem. Biophys. Res. Commun. 425 2012 290 296
14. C.C. Hsu, Y.W. Leu, M.J. Tseng, K.D. Lee, T.Y. Kuo, J.Y. Yen, Y.L. Lai, Y.C. Hung, W.S. Sun, C.M. Chen, P.Y. Chu, K.T. Yeh, P.S. Yan, Y.S. Chang, T.H. Huang, and S.H. Hsiao Functional characterization of Trip10 in cancer cell growth and survival J. Biomed. Sci. 18 2011 12
15. Y.W. Leu, P.S. Yan, M. Fan, V.X. Jin, J.C. Liu, E.M. Curran, W.V. Welshons, S.H. Wei, R.V. Davuluri, C. Plass, K.P. Nephew, and T.H. Huang Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer Cancer Res. 64 2004 8184 8192
16. E.E. Cameron, K.E. Bachman, S. Myohanen, J.G. Herman, and S.B. Baylin Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer Nat. Genet. 21 1999 103 107
17. + cancer stem cells in human liver cancer Cancer Cell 13 2008 153 166
18. S.H. Hsiao, K.D. Lee, C.C. Hsu, M.J. Tseng, V.X. Jin, W.S. Sun, Y.C. Hung, K.T. Yeh, P.S. Yan, Y.Y. Lai, H.S. Sun, Y.J. Lu, Y.S. Chang, S.J. Tsai, T.H. Huang, and Y.W. Leu DNA methylation of the Trip10 promoter accelerates mesenchymal stem cell lineage determination Biochem. Biophys. Res. Commun. 400 2010 305 312
19. H. Shi, S.H. Wei, Y.W. Leu, F. Rahmatpanah, J.C. Liu, P.S. Yan, K.P. Nephew, and T.H. Huang Triple analysis of the cancer epigenome: an integrated microarray system for assessing gene expression, DNA methylation and Histone Acetylation Cancer Res. 63 2003 2164 2171
20. P.S. Yan, C. Venkataramu, A. Ibrahim, J.C. Liu, R.Z. Shen, N.M. Diaz, B. Centeno, F. Weber, Y.W. Leu, C.L. Shapiro, C. Eng, T.J. Yeatman, and T.H. Huang Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 12 2006 6626 6636
21. Y.W. Leu, F. Rahmatpanah, H. Shi, S.H. Wei, J.C. Liu, P.S. Yan, and T.H. Huang Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation Cancer Res. 63 2003 6110 6115
22. R. Cao, and Y. Zhang The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3 Curr. Opin. Genet. Dev. 14 2004 155 164
23. N. Justin, V. De Marco, R. Aasland, and S.J. Gamblin Reading, writing and editing methylated lysines on histone tails: new insights from recent structural studies Curr. Opin. Struct. Biol. 20 2010 730 738
24. R. Margueron, and D. Reinberg The Polycomb complex PRC2 and its mark in life Nature 469 2011 343 349
25. C. Kohler, and C.B. Villar Programming of gene expression by polycomb group proteins Trends Cell Biol. 18 2008 236 243
26. B. Schuettengruber, A.M. Martinez, N. Iovino, and G. Cavalli Trithorax group proteins: switching genes on and keeping them active Nat. Rev. Mol. Cell Biol. 12 2011 799 814
27. N.M. Luis, L. Morey, L. Di Croce, and S.A. Benitah Polycomb in stem cells: PRC1 branches out Cell Stem Cell 11 2012 16 21
28. H. Richly, L. Aloia, and L. Di Croce Roles of the polycomb group proteins in stem cells and cancer Cell Death Dis. 2 2011 e204
29. Y.H. Chen, M.C. Hung, and L.Y. Li EZH2: a pivotal regulator in controlling cell differentiation Am. J. Trans. Res. 4 2012 364 375
30. J.E. Ohm, K.M. McGarvey, X. Yu, L. Cheng, K.E. Schuebel, L. Cope, H.P. Mohammad, W. Chen, V.C. Daniel, W. Yu, D.M. Berman, T. Jenuwein, K. Pruitt, S.J. Sharkis, D.N. Watkins, J.G. Herman, and S.B. Baylin A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing Nat. Genet. 39 2007 237 242
31. C. Balch, K.P. Nephew, T.H. Huang, and S.A. Bapat Epigenetic "bivalently marked" process of cancer stem cell-driven tumorigenesis BioEssays: News Rev. Mol. Cell. Dev.Biol. 29 2007 842 845
32. Y.W. Leu, T.H. Huang, and S.H. Hsiao Epigenetic reprogramming of mesenchymal stem cells Adv. Exp. Med. Biol. 754 2013 195 211
33. M. Krajewska, and M.A. van Vugt Building a great wall around mitosis: evolutionary conserved roles for the Greatwall/MASTL kinases in securing chromosome stability Cell Cycle 9 2010 3842
34. E. Manchado, M. Guillamot, G. de Carcer, M. Eguren, M. Trickey, I. Garcia-Higuera, S. Moreno, H. Yamano, M. Canamero, and M. Malumbres Targeting mitotic exit leads to tumor regression in vivo: modulation by Cdk1, Mastl, and the PP2A/B55alpha, delta phosphatase Cancer Cell 18 2010 641 654
35. J.I. Biederman, E. Vera, R. Rankhaniya, C. Hassett, G. Giannico, J. Yee, and P. Cortes Effects of sulfonylureas, alpha-endosulfine counterparts, on glomerulosclerosis in type 1 and type 2 models of diabetes Kidney Int. 67 2005 554 565
36. S.V. Guttula, A.A. Rao, G.R. Sridhar, M.S. Chakravarthy, K. Nageshwararo, and P.V. Rao Cluster analysis and phylogenetic relationship in biomarker identification of type 2 diabetes and nephropathy Int. J. Diab. Dev. Countries 30 2010 52 56